The EP3 receptor stimulates ceramide and diacylglycerol release and inhibits growth of primary keratinocytes

Experimental Dermatology

Volumn 14, Issue 12, 2005, Pages 914-922

  Konger, Raymond L ^a,c   Brouxhon, Sabine ^b   Partillo, Steven ^b   VanBuskirk, JoAnne ^b   Pentland, Alice P ^b  

^a INDIANA UNIVERSITY   (United States)

^b UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

^c Department of Pathology and Laboratory Medicine ^*  (United States)

Author keywords

Ceramide; Diacylglycerol; EP3 receptors; Growth inhibition; Immunolocalization

Indexed keywords

CERAMIDE; CYCLIN DEPENDENT KINASE INHIBITOR 1; DIACYLGLYCEROL; PROSTAGLANDIN E RECEPTOR; SULPROSTONE; 1,2-DIACYLGLYCEROL; CDKN1A PROTEIN, HUMAN; CYCLIN DEPENDENT KINASE INHIBITOR 1A; PROSTAGLANDIN EP3 RECEPTOR; RECOMBINANT DNA;

ARTICLE; CELL DIFFERENTIATION; CELL GROWTH; CELL PROLIFERATION; CELLULAR DISTRIBUTION; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; GENE EXPRESSION; GENETIC VARIABILITY; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IMMUNOLOCALIZATION; KERATINOCYTE; MOLECULAR MECHANICS; NORTHERN BLOTTING; PROTEIN LOCALIZATION; REGULATORY MECHANISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; WESTERN BLOTTING; CELL CULTURE; CYTOLOGY; EPIDERMIS; GENETICS; METABOLISM; PHYSIOLOGY; TISSUE DISTRIBUTION;

BLOTTING, WESTERN; CELL PROLIFERATION; CELLS, CULTURED; CERAMIDES; CYCLIN-DEPENDENT KINASE INHIBITOR P21; DIGLYCERIDES; DNA, RECOMBINANT; EPIDERMIS; HUMANS; IMMUNOHISTOCHEMISTRY; KERATINOCYTES; RECEPTORS, PROSTAGLANDIN E; TISSUE DISTRIBUTION;

EID: 28444491736     PISSN: 09066705     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0625.2005.00381.x     Document Type: Article

References (45)

1. Prescott S M, Fitzpatrick F A. Cyclooxygenase-2 and carcinogenesis. Biochim Biophys Acta 2000: 1470: M69-M78.
2. Buckman S Y, Gresham A, Hale P et al. COX-2 expression is induced by UVB exposure in human skin: implications for the development of skin cancer. Carcinogenesis 1998: 19: 723-729.
3. Golijanin D, Tan J Y, Kazior A et al. Cyclooxygenase-2 and microsomal prostaglandin E synthase-1 are overexpressed in squamous cell carcinoma of the penis. Clin Cancer Res 2004: 10: 1024-1031.
4. Fischer S M, Lo Hh, Gordon G B et al. Chemopreventive activity of celecoxib, a specific cyclooxygenase-2 inhibitor, and indomethacin against ultraviolet light-induced skin carcinogenesis. Mol Carcinog 1999: 25: 231-240.
5. Marks F, Furstenberger G. Cancer chemoprevention through interruption of multistage carcinogenesis. The lessons learnt by comparing mouse skin carcinogenesis and human large bowel cancer. Eur J Cancer 2000: 36: 314-329.
6. Pentland A P, Schoggins J W, Scott G A, Khan K N, Han R. Reduction of UV-induced skin tumors in hairless mice by selective COX-2 inhibition. Carcinogenesis 1999: 20: 1939-1944.
7. Urquhart J. Some key points emerging from the COX-2 controversy. Pharmacoepidemiol Drug Saf 2005: 14: 145-147.
8. Breyer R M, Bagdassarian C K, Myers S A, Breyer M D. Prostanoid receptors: subtypes and signaling. Annu Rev Pharmacol Toxicol 2001: 41: 661-690.
9. Abramovitz M, Adam M, Boie Y et al. The utilization of recombinant prostanoid receptors to determine the affinities and selectivities of prostaglandins and related analogs. Biochim Biophys Acta 2000: 1483: 285-293.
10. 3 subtypes. Biochim Biophys Acta 1998: 1401: 221-234.
11. 3 receptor signaling. J Biochem (Tokyo) 2002: 131: 781-784.
12. 3 subtype generated by alternative messenger RNA splicing: multiple second messenger systems and tissue-specific distributions. Mol Pharmacol 1995: 48: 869-879.
13. Yuspa Sh, Punnonen K, Lee E et al. The in vitro analysis of biochemical changes relevant to skin carcinogenesis. Recent Results Cancer Res 1993: 128: 299-308.
14. Bollinger Bollag W, Bollag R J. 1,25-dihydroxyvitamin D(3), phospholipase D and protein kinase C in keratinocyte differentiation. Mol Cell Endocrinol 2001: 177: 173-182.
15. Mimeault M, Bonenfant D, Batra S K. New advances on the functions of epidermal growth factor receptor and ceramides in skin cell differentiation, disorders and cancers. Skin Pharmacol Physiol 2004: 17: 153-166.
16. Kallassy M, Martel N, Damour O, Yamasaki H, Nakazawa H. Growth arrest of immortalized human keratinocytes and suppression of telomerase activity by p21WAF1 gene expression. Mol Carcinog 1998: 21: 26-36.
17. Todd C, Reynolds N J. Up-regulation of p21WAF1 by phorbol ester and calcium in human keratinocytes through a protein kinase C-dependent pathway. Am J Pathol 1998: 153: 39-45.
18. Harvat B L, Wang A, Seth P, Jetten A M. Up-regulation of p27Kip1, 21WAF1/Cip1 and p16Ink4a is associated with, but not sufficient for, induction of squamous differentiation. J Cell Sci 1998: 111 (Pt 9): 1185-1196.
19. Lehtonen J Y, Horiuchi M, Daviet L, Akishita M, Dzau V J. Activation of the de novo biosynthesis of sphingolipids mediates angiotensin II type 2 receptor-induced apoptosis. J Biol Chem 1999: 274: 16901-16906.
20. Guzman M, Galve-Roperh I, Sanchez C. Ceramide: a new second messenger of cannabinoid action. Trends Pharmacol Sci 2001: 22: 19-22.
21. Liu G, Ghahremani Mh, Banihashemi B, Albert P R. Diacylglycerol and ceramide formation induced by dopamine D2S receptors via Gbeta gamma-subunits in Ba1b/c-3T3 cells. Am J Physiol Cell Physiol 2003: 284: C640-C648.
22. Gallinat S, Busche S, Schutze S, Kronke M, Unger T. AT2 receptor stimulation induces generation of ceramides in PC12W cells. FEBS Lett 1999: 443: 75-79.
23. 2, in adult human epidermis. J Invest Dermatol 2005: 124: 965-970.
24. Wright T M, Rangan L A, Shin H S, Raben D M. Kinetic analysis of 1,2-diacylglycerol mass levels in cultured fibroblasts. Comparison of stimulation by alpha-thrombin and epidermal growth factor. J Biol Chem 1988: 263: 9374-9380.
25. Van Veldhoven P P, Bishop W R, Yurivich D A, Bell R M. Ceramide quantitation: evaluation of a mixed micellar assay using E. coli diacylglycerol kinase. Biochem Mol Biol Int 1995: 36: 21-30.
26. Rys-Sikora K E, Konger R L, Schoggins J W, Malaviya R, Pentland A P. Coordinate expression of secretory phospholipase A(2) and cyclooxygenase-2 in activated human keratinocytes. Am J Physiol Cell Physiol 2000: 278: C822-C833.
27. 3beta for correct sorting to the plasma membrane but not for correct folding. Biochem 12000: 350: 839-847.
28. 4 in the nuclear envelope. J Biol Chem 1999: 274: 15719-15724.
29. Lee Y S, Yuspa Sh, Dlugosz A A. Differentiation of cultured human epidermal keratinocytes at high cell densities is mediated by endogenous activation of the protein kinase C signaling pathway. J Invest Dermatol 1998: 111: 762-766.
30. Geilen C C, Barz S, Bektas M. Sphingolipid signaling in epidermal homeostasis. Current knowledge and new therapeutic approaches in dermatology. Skin Pharmacol Appl Skin Physiol 2001: 14: 261-271.
31. Zhu X F, Liu Z C, Xie B F, Feng G K, Zeng Y X. Ceramide induces cell cycle arrest and upregulates p27kip in nasopharyngeal carcinoma cells. Cancer Lett 2003: 193: 149-154.
32. 2-induced sensitization of polymodal receptors in response to bradykinin and heat. J Neurophysiol 1996: 75: 2361-2368.
33. Kiriyama M, Ushikubi F, Kobayashi T, Hirata M, Sugimoto Y, Narumiya S. Ligand binding specificities of the eight types and subtypes of the mouse prostanoid receptors expressed in Chinese hamster ovary cells. Br J Pharmacol 1997: 122: 217-224.
34. Casibang M, Moody T W. AH6809 antagonizes nonsmall cell lung cancer prostaglandin receptors. Lung Cancer 2002: 36: 33-42.
35. Vrana J A, Kramer L B, Saunders A M et al. Inhibition of protein kinase C activator-mediated induction of p21CIP1 and p27KIP1 by deoxycytidine analogs in human leukemia cells: relationship to apoptosis and differentiation. Biochem Pharmacol 1999: 58: 121-131.
36. Pentland A P, Needleman P. Modulation of keratinocyte proliferation in vitro by endogenous prostaglandin synthesis. J Clin Invest 1986: 77: 246-251.
37. Shoji Y, Takahashi M, Kitamura T et al. Downregulation of prostaglandin E receptor subtype EP3 during colon cancer development. Gut 2004: 53: 1151-1158.
38. Jensen J-M, Forl M, Winoto-Morbach S et al. Acid and neutral sphingomyelinase, ceramide synthase, and acid ceramidase activities in cutaneous aging. Exp Dermatol 2005: 14: 609-618.
39. Vazquez-Tello A, Fan L, Hou X et al. Intracellular-specific colocalization of prostaglandin E2 synthases and cyclooxygenases in the brain. Am J Physiol Regul Integr Comp Physiol 2004: 287: R1155-R1163.
40. Kojima F, Naraba H, Sasaki Y, Okamoto R, Koshino T, Kawai S. Coexpression of microsomal prostaglandin E synthase with cyclooxygenase-2 in human rheumatoid synovial cells. J Rheumatol 2002: 29: 1836-1842.
41. Asirvatham A L, Galligan S G, Schillace R V et al. A-kinase anchoring proteins interact with phosphodiesterases in T lymphocyte cell lines. J Immunol 2004: 173: 4806-4814.
42. Saraste J, Palade G E, Farquhar M G. Antibodies to rat pancreas Golgi subfractions: identification of a 58-kD cis-Golgi protein. J Cell Biol 1987: 105: 2021-2029.
43. 2 receptors on U937 human monocyte cells. Immunology 1995: 86: 620-628.
44. Buckman S Y, Koki A T, Edwards D A, Pentland A P. Immunohistochemical analysis of cyclooxygenase expression in human skin. Methods Mol Biol 1999: 120: 35-43.
45. Pentland A P. Cyclooxygenase inhibitors for skin cancer prevention: are they beneficial enough? Arch Dermatol 2002: 138: 823-824 (Letter, Comment).